Moreover, the expression of MAP1LC3B, ATG5, ATG10, RB1CC1, and AMBRA1 genes was assessed in seven AML patients in the relapse phase and compared with that of 32 newly diagnosed AML patients. Here, AMBRA1 is linked to acute myeloid leukemia.